Members of Congress Circulate Bipartisan Letter to HHS to Protect the Integrity of the 340B Drug Discount Program

This week, Representatives Spanberger (D-VA), Axne (D-IA), McKinley (R-WV), Johnson (R-SD), Katko (R-NY), and Matsui (D-CA) began circulating a bipartisan sign-on letter that calls on Health and Human Services (HHS) Secretary nominee, Xavier Becerra, to address drug manufacturers’ refusal to provide 340B drug discounts to covered entities utilizing contract pharmacy arrangements.  RWC-340B was a key…

Further Cuts to 340B Would Be ‘Devastating’

As legislators continued to debate the future of the 340B drug discount program on Wednesday, leaders at several major health systems in both urban and rural settings raised concerns over the serious risks they face if those savings sustain significant cuts. Already, those reductions have forced West Virginia University Medicine—which serves a large, rural population—to “regroup” and…